Detalhe da pesquisa
1.
WITHDRAWN: Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 2 phase 3, 29-day, randomized, controlled REVEAL trials.
J Am Acad Dermatol
; 2018 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-29409915